Jointly Provided by Rutgers Biomedical and Health Sciences and the Southern New Jersey Perinatal Cooperative

In collaboration with the March of Dimes 

Supported by an educational grant from AMAG Pharmaceuticals, Inc.

Release Date: December 31, 2018
Expiration Date: December 31, 2019
Estimated time to complete this activity as designed is 1 hour.

Reducing the nation's preterm birth rate to 5.5% by 2030 is an ambitious goal.  This on-demand webinar contributes to the realization of that urgent objective with the knowledge and tools for substantive impact. The agenda includes updates on leading prevention strategies such as birth spacing, low dose aspirin and 17 alpha-hydroxyprogesterone caproate (17P); as well as a discussion of new care models, the impact of racial disparity and role of perinatal risk assessment. Participants will gain a thorough understanding of increased risks for preterm birth, barriers to women receiving appropriate treatment and how the enhanced Perinatal Risk Assessment Tool can be used for patient care.

Presenting Faculty
Lisa Gittens-Williams, MD
Associate Professor of Obstetrics, Gynecology and Women's Health
Division of Maternal Fetal Medicine
Rutgers New Jersey Medical School
Newark, NJ

Donna Bordner
Program Coordinator, Family Health Initiatives
Southern New Jersey Perinatal Cooperative
Pennsauken, NJ

1. Recognize the significance of preterm birth on neonatal mortality and morbidity
2. Review perinatal risk assessment strategies conducted during pregnancy to identify who is at risk for fetal infant death or infant mortality
3. Describe the treatment modalities that are effective in reducing preterm births

In order to access the content, please click on the "Register" tab and complete your registration.  Once registered, please click on the "Online Content & Tests" tab and select "Launch Website" to view the on-demand webinar. 

How to Receive CE Credit: Participants should review the activity in its entirety and then complete the post-test, which is accessible on the "Online Content & Tests" tab and consists of a series of multiple choice questions. Upon completing this activity as designed, achieving a passing score of 70% or more on the post-test, and completing the evaluation, participants will be able to download their CE certificate. The CE certificate will also be emailed to you.

In support of improving patient care, this activity has been designed and implemented by Rutgers Biomedical and Health Sciences and Southern New Jersey Perinatal Cooperative. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity is awarded 1 contact hour. (60 minute CH)

Peer Review: In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, Rutgers Biomedical and Health Sciences (RBHS) has resolved all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers. This activity was peer reviewed for relevance, accuracy of content and balance of presentation by: Jacquelyn S. Loughlin, MD Associate Professor of Obstetrics, Gynecology and Women's Health, Division of Maternal Fetal Medicine, Rutgers New Jersey Medical School Newark, NJ and Karen Romano, RN, MS, Practice Manager, OB/GYN Associates, University Hospital, Newark, NJ.

Field Test: This activity was pilot-tested for time required for participation by Shivani Agarwal, MD, Karen L. Dudley, RN, Angela Huang, MD, Jonathan Jimenez, MD, Patricia Kelley-Williams, RN, and Ann Nascondiglio, RN, MBA, BSN, COHN-S.

Disclosure: In accordance with the disclosure policies of Rutgers and to conform with Joint Accreditation requirements and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: (1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and (2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device that is not yet approved.

The following individuals have no relevant financial relationships to disclose:

Faculty
Lissa Gittens-Williams, MD
Donna Bordner

Reviewers
Jacquelyn S. Loughlin, MD
Karen Romano, RN, MS

Planning Committee
Patrick Dwyer - Director, Continuing Medical Education, RBHS Center for Continuing and Outreach Education
Helen Hannigan, BS, MGA - Director, MIS and Administration, and COO, Family Health Initiatives, Southern New Jersey Perinatal Cooperative
Helene Lynch - Director, Operations, Southern New Jersey Perinatal Cooperative
Laurie Navin - Director of Professional Development and Community Engagement, Central Jersey Family Health Consortium
Ellen Shuzman, PhD, RN, CNAA, APN - Director of Education and Professional Development, Central Jersey Family Health Consortium
Amy Gole, RNC-MNN, EdM, NE-BC, FACCE, IBCLC - Director of Education, Partnership for Maternal and Child Health of Northern New Jersey
Ellen Silver, MD - Private Practice
Ksenia Zukowsky, PhD, NNP-BC - Senior Associate Dean for Graduate Programs, Jefferson College of Nursing

Field Testers
Shivani Agarwal, MD
Karen L. Dudley, RN
Angela Huang, MD
Jonathan Jimenez, MD
Patricia Kelley-Williams, RN
Ann Nascondiglio, RN, MBA, BSN, COHN-S

This activity does not contain information about commercial products/devices that are unlabeled for use or investigational products not yet approved.

Content Disclaimer: The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, Rutgers University, the Southern New Jersey Perinatal Cooperative, or the March of Dimes of New Jersey.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states and assessments of risks are based upon a combination of clinical trials, current guidelines and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products or procedures before using them in clinical practice.

Copyright © 2018-2019 Rutgers Biomedical and Health Sciences and the Southern New Jersey Perinatal Cooperative. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval systems without written permission from Rutgers.

Questions: Please direct content, continuing education or technical questions or concerns to RBHS Center for Continuing and Outreach Education (CCOE) at 973-972-4267 or email ccoe@ca.rutgers.edu.

To review CCOE's privacy policy, please click here.

No faculty are available for this activity at this time.